Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Mango
BRIGHT MINDS BIOSCIENCES INC.
Overweight or Obesity
1 trial -
Maternal Nutritional Supplement
Abbott Australasia Pty Ltd
Breast Feeding
1 trial -
Meat Biscuit
United Therapeutics Europe Ltd
HIV Infections
1 trial -
Medical Treatment
The First People's Hospital of Lianyungang
Basilar Artery Occlusion
1 trial -
Medication for opioid-use disorder (MOUD) for opioid-use disorder (OUD)
BRIGHT MINDS BIOSCIENCES INC.
HIV Infections
1 trial -
Medium-quantity lipid-based nutrient supplement (MQ-LNS)
United Therapeutics Europe Ltd
Undernutrition
1 trial -
Medolac human milk based human milk fortifier (MHMHMF)
NORTHWEST BIOTHERAPEUTICS INC
Infant, Premature, Diseases
1 trial -
Metformin hydrochloride sustained release tablets
The First People's Hospital of Lianyungang
Osteoarthritis
1 trial -
Metformin pretreatment before ovarian stimulation
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Metformin
1 trial -
Methylphenidate HCl ER tablets 1
BRIGHT MINDS BIOSCIENCES INC.
Attention Deficit Hyperactivity Disorder
1 trial -
Mindfulness meditation based on brain-computer interface
The First People's Hospital of Lianyungang
Atrial Fibrillation
1 trial -
Minocycline
The First People's Hospital of Lianyungang
Intracerebral Hemorrhage
1 trial -
Mitoxantrone hydrochloride liposome injection
The First People's Hospital of Lianyungang
Diffuse Large B-cell Lymphoma
1 trial -
Miyarisan-BM (Clostridium Butyricum Miyairi)
Hospital Authority, Hong Kong
Clostridium Butyricum Miyairi
1 trial -
Modafinil Oral Tablet
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy
1 trial -
Morphine
BRIGHT MINDS BIOSCIENCES INC.
Sleep Deprivation
1 trial -
Multi-component Interventions
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Multimorbidity
1 trial -
Multi-component intervention package
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Multimorbidity
1 trial -
Multistrain Probiotic
Ultragenyx UK Limited
Cystic Fibrosis in Children
1 trial -
Multivitamins
BRIGHT MINDS BIOSCIENCES INC.
HIV Infections
1 trial -
Mupirocin (drug)
Hospital Authority, Hong Kong
Biopsy Wound
1 trial -
N-butyl-2-cyanoacrylate
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastric Varices
1 trial -
NBP Softgel Capsules
The First People's Hospital of Lianyungang
Migraine
1 trial -
Nab-paclitaxel
The First People's Hospital of Lianyungang
Pancreatic Cancer
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources